These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38171084)

  • 1. Evaluating the Safety and Efficacy of Erythropoietin Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-Analysis.
    Marsia S; Kumar D; Raheel H; Salman A; Aslam B; Ikram A; Kumar P; Aslam A; Shafiq A; Gul A
    Pediatr Neurol; 2024 Mar; 152():4-10. PubMed ID: 38171084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
    Razak A; Hussain A
    J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research.
    Oorschot DE; Sizemore RJ; Amer AR
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of monotherapy with erythropoietin in neonatal hypoxic-ischemic encephalopathy on neurobehavioral development: a systematic review and meta-analysis.
    Liu TS; Yin ZH; Yang ZH; Wan LN
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2318-2326. PubMed ID: 33755969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic hypothermia in neonatal hypoxic encephalopathy: A systematic review and meta-analysis.
    Mathew JL; Kaur N; Dsouza JM
    J Glob Health; 2022; 12():04030. PubMed ID: 35444799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
    Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
    Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
    Wu YW; Comstock BA; Gonzalez FF; Mayock DE; Goodman AM; Maitre NL; Chang T; Van Meurs KP; Lampland AL; Bendel-Stenzel E; Mathur AM; Wu TW; Riley D; Mietzsch U; Chalak L; Flibotte J; Weitkamp JH; Ahmad KA; Yanowitz TD; Baserga M; Poindexter BB; Rogers EE; Lowe JR; Kuban KCK; O'Shea TM; Wisnowski JL; McKinstry RC; Bluml S; Bonifacio S; Benninger KL; Rao R; Smyser CD; Sokol GM; Merhar S; Schreiber MD; Glass HC; Heagerty PJ; Juul SE;
    N Engl J Med; 2022 Jul; 387(2):148-159. PubMed ID: 35830641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo.
    Glass HC; Wusthoff CJ; Comstock BA; Numis AL; Gonzalez FF; Maitre N; Massey SL; Mayock DE; Mietzsch U; Natarajan N; Sokol GM; Bonifacio SL; Van Meurs KP; Thomas C; Ahmad KA; Heagerty PJ; Juul SE; Wu YW
    Pediatr Res; 2023 Jul; 94(1):252-259. PubMed ID: 36470964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
    Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
    Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial.
    Malla RR; Asimi R; Teli MA; Shaheen F; Bhat MA
    J Perinatol; 2017 May; 37(5):596-601. PubMed ID: 28277490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility.
    Nonomura M; Harada S; Asada Y; Matsumura H; Iwami H; Tanaka Y; Ichiba H
    BMC Pediatr; 2019 Jan; 19(1):13. PubMed ID: 30621649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.
    Traudt CM; McPherson RJ; Bauer LA; Richards TL; Burbacher TM; McAdams RM; Juul SE
    Dev Neurosci; 2013; 35(6):491-503. PubMed ID: 24192275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews.
    Shepherd E; Salam RA; Middleton P; Han S; Makrides M; McIntyre S; Badawi N; Crowther CA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012409. PubMed ID: 29926474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial.
    Juul SE; Comstock BA; Cornet MC; Gonzalez FF; Mayock DE; Glass HC; Schreiber MD; Heagerty PJ; Wu YW
    J Pediatr; 2023 Jul; 258():113400. PubMed ID: 37019334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Neuropathological Changes Associated with Cerebral Palsy in a Nonhuman Primate Model of Hypoxic-Ischemic Encephalopathy.
    McAdams RM; Fleiss B; Traudt C; Schwendimann L; Snyder JM; Haynes RL; Natarajan N; Gressens P; Juul SE
    Dev Neurosci; 2017; 39(1-4):124-140. PubMed ID: 28486224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?
    Wu YW; Gonzalez FF
    Dev Med Child Neurol; 2015 Apr; 57 Suppl 3():34-9. PubMed ID: 25800490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin for infants with hypoxic-ischemic encephalopathy.
    McPherson RJ; Juul SE
    Curr Opin Pediatr; 2010 Apr; 22(2):139-45. PubMed ID: 20090525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
    Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cerebral metabolic rate following therapeutic hypothermia with 18-month neurodevelopmental outcomes after neonatal hypoxic ischemic encephalopathy.
    Sutin J; Vyas R; Feldman HA; Ferradal S; Hsiao CH; Zampolli L; Pierce LJ; Nelson CA; Morton SU; Hay S; El-Dib M; Soul JS; Lin PY; Grant PE
    EBioMedicine; 2023 Aug; 94():104673. PubMed ID: 37392599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial.
    Ezenwa B; Ezeaka C; Fajolu I; Ogbenna A; Olowoyeye O; Nwaiwu O; Opoola Z; Olorunfemi G
    BMC Neurol; 2020 May; 20(1):171. PubMed ID: 32366288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.